Soligenix
SNGX
#10223
Rank
$16.23 M
Marketcap
$1.61
Share price
-1.23%
Change (1 day)
-49.69%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -$3.24

According to Soligenix's latest financial reports the company's current EPS (TTM) is -$3.24. In 2024 the company made an earnings per share (EPS) of -$4.98 an increase over its 2023 EPS that were of -$12.66.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$3.24-34.94%
2024-$4.98-60.66%
2023-$12.66-83.55%
2022-$76.9613.95%
2021-$67.54-56.03%
2020-$153.6033.33%
2019-$115.20-29.41%
2018-$163.20-41.38%
2017-$278.4024.73%
2016-$223.20-69%
2015-$720.00-6.25%
2014-$768.00-50.77%
2013-$1,56075.68%
2012-$888.0068.18%
2011-$528.00-69.86%
2010-$1,752-8.75%
2009-$1,92033.33%
2008-$1,440-57.14%
2007-$3,360-46.15%
2006-$6,24044.44%
2005-$4,320-40.7%
2004-$7,285-15.62%
2003-$8,635-25.52%
2002-$11,593-80.94%
2001-$60,821160.89%
2000-$23,313-40.57%
1999-$39,225-63.84%
1998-$108,480601.73%
1997-$15,459101.7%
1996-$7,664

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Emergent BioSolutions
EBS
$1.41-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$3.71-214.37%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
$1.72-153.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$10.44-422.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$2.03-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$0.95-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$0.63-119.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel